Abstract:Primary liver cancer accounts for the third most deadly type of malignant tumor globally, and approximately 80% of the cases are hepatocellular carcinoma (HCC), which highly relies on the activity of hypoxia responsive pathways to bolster its metastatic behaviors. MicroRNA-29a (MIR29A) has been shown to exert a hepatoprotective effect on hepatocellular damage and liver fibrosis induced by cholestasis and diet stress, while its clinical and biological role on the activity hypoxia responsive genes including LOX, LOXL2, and VEGFA remains unclear. TCGA datasets were retrieved to confirm the differential expression and prognostic significance of all genes in the HCC and normal tissue. The Gene Expression Omnibus (GEO) dataset was used to corroborate the differential expression and diagnostic value of MIR29A. The bioinformatic identification were conducted to examine the interaction of MIR29A with LOX, LOXL2, and VEGFA. The suppressive activity of MIR29A on LOX, LOXL2, and VEGF was verified by qPCR, immunoblotting, and luciferase. The effect of overexpression of MIR29A-3p mimics in vitro on apoptosis markers (caspase-9, -3, and poly (ADP-ribose) polymerase (PARP)); cell viability and wound healing performance were examined using immunoblot and a WST-1 assay and a wound healing assay, respectively. The HCC tissue presented low expression of MIR29A, yet high expression of LOX, LOXL2, and VEGFA as compared to normal control. Serum MIR29A of HCC patients showed decreased levels as compared to that of normal control, with an area under curve (AUC) of 0.751 of a receiver operating characteristic (ROC) curve. Low expression of MIR29A and high expression of LOX, LOXL2, and VEGFA indicated poor overall survival (OS). MIR29A-3p was shown to target the 3′UTR of LOX, LOXL2, and VEGFA. Overexpression of MIR29A-3p mimic in HepG2 cells led to downregulated gene and protein expression levels of LOX, LOXL2, and VEGFA, wherein luciferase reporter assay confirmed that MIR29A-3p exerts the inhibitory activity via directly binding to the 3′UTR of LOX and VEGFA. Furthermore, overexpression of MIR29A-3p mimic induced the activity of caspase-9 and -3 and PARP, while it inhibited the cell viability and wound healing performance. Collectively, this study provides novel insight into a clinical-applicable panel consisting of MIR29, LOX, LOXL2, and VEGFA and demonstrates an anti-HCC effect of MIR29A via comprehensively suppressing the expression of LOX, LOXL2, and VEGFA, paving the way to a prospective theragnostic approach for HCC.

Tumor-suppressor P53 Specifically Binds to Mir-29C-3p and Reduces ADAM12 Expression in Hepatocellular Carcinoma

MiR-875-5p suppresses Gli1 to alter the hedgehog signaling pathway, which in turn has hepatocellular cancer-related tumor suppressing properties

MiR-29a Suppresses Cell Proliferation by Targeting SIRT1 in Hepatocellular Carcinoma

P53 Suppresses the Progression of Hepatocellular Carcinoma Via Mir-15A by Decreasing OGT Expression and EZH2 Stabilization.

Mir-203 Suppresses the Proliferation and Metastasis of Hepatocellular Carcinoma by Targeting Oncogene ADAM9 and Oncogenic Long Non-Coding RNA HULC.

Abstract 3081: Mir-885-5p, a P53-Activated Microrna, Inhibits the Wnt/β-catenin Signaling Pathway and Hepatocellular Carcinoma Metastasis.

Mir-19b Promotes Tumor Growth and Metastasis Via Targeting Tp53

Downregulation of Mir-193A-3p is Involved in the Pathogenesis of Hepatocellular Carcinoma by Targeting CCND1

Mir-532-3p Promotes Hepatocellular Carcinoma Progression by Targeting PTPRT.

Molecular Mechanism of the Mir-7/Bcl2l1/p53 Signaling Axis Regulating the Progression of Hepatocellular Carcinoma

MIR29A Impedes Metastatic Behaviors in Hepatocellular Carcinoma via Targeting LOX, LOXL2, and VEGFA

Mir-218 Modulate Hepatocellular Carcinoma Cell Proliferation Through PTEN/AKT/PI3K Pathway and HoxA10.

Up-Regulation Of Mir-95-3p In Hepatocellular Carcinoma Promotes Tumorigenesis By Targeting P21 Expression

Down-regulation of MAP2K1 by Mir-539 Inhibits Hepatocarcinoma Progression.

MicroRNA‑574‑3p Inhibits the Malignant Behavior of Liver Cancer Cells by Targeting ADAM28

P53-induced Mir-1249 Inhibits Tumor Growth, Metastasis, and Angiogenesis by Targeting VEGFA and HMGA2

Mir-300 Promotes Proliferation and Emt-Mediated Colorectal Cancer Migration and Invasion by Targeting P53

Mir-107 Suppresses Proliferation of Hepatoma Cells Through Targeting Hmga2 Mrna 3 ' Utr

MicroRNA-377-3p Promotes Cell Proliferation and Inhibits Cell Cycle Arrest and Cell Apoptosis in Hepatocellular Carcinoma by Affecting EGR1-mediated P53 Activation.

Lncrna XIST Regulates Proliferation and Migration of Hepatocellular Carcinoma Cells by Acting As Mir-497-5p Molecular Sponge and Targeting PDCD4

Mir‐1287 Suppresses the Proliferation, Invasion, and Migration in Hepatocellular Carcinoma by Targeting PIK3R3